<html>
<head>PUBMED IDs for REPS2</head>
<body bgcolor='#C5F0F2'><h1>REPS2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12771942/'>REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells.</a> May 29  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15010845/'>Identification and characterization of human GUKH2 gene in silico.</a> March 11  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15455380/'>EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2.</a> September 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/19776672/'>TMEM25, REPS2 and Meis 1: favourable prognostic and predictive biomarkers for breast cancer.</a> November 5  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20613765/'>Copy-number variations on the X chromosome in Japanese patients with mental retardation detected by array-based comparative genomic hybridization analysis.</a> February 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20882036/'>Identification of a microdeletion at Xp22.13 in a Taiwanese family presenting with Nance-Horan syndrome.</a> May 10  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22976541/'>Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.</a> February 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23803043/'>Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.</a> January 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25788273/'>Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer.</a> March 5  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27120794/'>miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.</a> April 28  2016<br></body></html>
